InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,466.66
(
0.34%
)
US TECH 100
19,150.80
(
1.01%
)
Dow Jones
39,156.49
(
-0.65%
)
Brent Oil
84.13
(
-1.34%
)
Bitcoin
61,883.95
(
2.69%
)
Post# of 37328
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lloydm

Send PM Follow Ignore
Followers 16
Posts 931
Boards Moderated 0
Alias Born 08/03/2015

lloydm

Re: None

Wednesday, 12/09/2015 8:44:30 AM

Wednesday, December 09, 2015 8:44:30 AM

Post# of 37328
NEWS

08:22 AM EST, 12/09/2015 (MT Newswires) --(GBSN) shares were higher nearly 7% in recent pre-market trade after saying its shareholders have approved a reverse stock split at a ratio between 1-for-50 and 1-for-60, to be decided by the board.
The molecular diagnostics company said shareholders didn't approve increasing the company's authorized shares to 950 million from 200 million.
The reverse split will also cure the company's previously announced authorized share failure and the series C warrants will become exercisable for the following 25 trading days.
GBSN trades near the bottom of the 52-week range between $0.05 and $6.10.
Price: 0.12, Change: +0.01, Percent Change: +6.70
http://www.mtnewswires.com Copyright © 2015 MTNewswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

Nothing I state is intended to be a recommendation to buy or sell, opinion only. Readers are solely responsible for how they use the information.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up